MARY A FLETCHER

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. pmc Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue
    Gordon Broderick
    Division of Pulmonary Medicine, Department of Medicine, University of Alberta, WMC 2E4 41 WC Mackenzie Health Sciences Centre, 8440 112 Street, Edmonton, AB T6G 2R7, Canada
    J Transl Med 10:191. 2012
  2. pmc A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome
    Anne Liese Smylie
    Department of Medicine, University of Alberta, Edmonton, AB, Canada
    BMC Immunol 14:29. 2013
  3. doi request reprint Psychoneuroimmunology and natural killer cells: the chromium release whole blood assay
    Mary Ann Fletcher
    Department of Medicine, University of Miami, Miami, FL, USA
    Methods Mol Biol 934:313-24. 2012
  4. pmc Impaired immune function in Gulf War Illness
    Toni Whistler
    Chronic Viral Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    BMC Med Genomics 2:12. 2009
  5. pmc Plasma cytokines in women with chronic fatigue syndrome
    Mary Ann Fletcher
    Department of Medicine, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, FL, USA
    J Transl Med 7:96. 2009
  6. pmc Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26
    MARY A FLETCHER
    Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    PLoS ONE 5:e10817. 2010
  7. pmc Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome
    MARY A FLETCHER
    Department of Medicine, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, FL USA
    Behav Brain Funct 6:76. 2010

Collaborators

Detail Information

Publications7

  1. pmc Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue
    Gordon Broderick
    Division of Pulmonary Medicine, Department of Medicine, University of Alberta, WMC 2E4 41 WC Mackenzie Health Sciences Centre, 8440 112 Street, Edmonton, AB T6G 2R7, Canada
    J Transl Med 10:191. 2012
    ..We studied 301 adolescents prospectively over 24 months following the diagnosis of monospot-positive infectious mononucleosis (IM). We found an incidence of CFS at 6, 12 and 24 months of 13%, 7% and 4% respectively...
  2. pmc A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome
    Anne Liese Smylie
    Department of Medicine, University of Alberta, Edmonton, AB, Canada
    BMC Immunol 14:29. 2013
    ....
  3. doi request reprint Psychoneuroimmunology and natural killer cells: the chromium release whole blood assay
    Mary Ann Fletcher
    Department of Medicine, University of Miami, Miami, FL, USA
    Methods Mol Biol 934:313-24. 2012
    ..Target cells are the K562 eyrthroleukemia cell line. Killing capacity is defined as number of target cells killed per effector cell, at an effector cell/target cell ratio of 1:1 during a 4 h in vitro assay...
  4. pmc Impaired immune function in Gulf War Illness
    Toni Whistler
    Chronic Viral Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA
    BMC Med Genomics 2:12. 2009
    ..Our results do not necessarily elucidate the cause of GWI, but they do reveal a role for immune cell dysfunction in sustaining illness...
  5. pmc Plasma cytokines in women with chronic fatigue syndrome
    Mary Ann Fletcher
    Department of Medicine, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, FL, USA
    J Transl Med 7:96. 2009
    ..No widely accepted laboratory test or marker is available for the diagnosis or prognosis of CFS. This study screened plasma factors to identify circulating biomarkers associated with CFS...
  6. pmc Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26
    MARY A FLETCHER
    Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA
    PLoS ONE 5:e10817. 2010
    ..However, neither these assays nor other laboratory tests are widely accepted for the diagnosis or prognosis of CFS. This study sought to determine if NKCC or DPPIV/CD26 have diagnostic accuracy for CFS...
  7. pmc Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome
    MARY A FLETCHER
    Department of Medicine, University of Miami Miller School of Medicine, 1600 NW 10th Ave, Miami, FL USA
    Behav Brain Funct 6:76. 2010
    ..Abnormalities in stress responses have been identified as potential triggers or mediators of CFS symptoms. This study focused on the stress mediator neuropeptide Y (NPY). We hypothesized that NPY would be a useful biomarker for CFS...

Research Grants6

  1. Neuropeptide Y and dipeptidyl-peptidase IV (CD26) in chronic fatigue syndrome
    Mary Fletcher; Fiscal Year: 2007
    ..Specific Aim 3 is to define the relationship of NPY and CD26 to NKCC in CFS. Specific Aim 4 is to determine the relationship of NPY and CD26 to clinical severity in CFS patients. ..
  2. Immunologic Mechanisms, Biomarkers and Subsets in Chronic Fatigue Syndrome (CFS)
    MARY A FLETCHER; Fiscal Year: 2010
    ..By defining immune function at the molecular level, we will identify potential biomarkers and targets for intervention with immuno-modulatory therapies and the means to measure the efficacy of these therapies. ..
  3. Immunologic Mechanisms, Biomarkers and Subsets in Chronic Fatigue Syndrome (CFS)
    MARY A FLETCHER; Fiscal Year: 2011
    ..By defining immune function at the molecular level, we will identify potential biomarkers and targets for intervention with immuno-modulatory therapies and the means to measure the efficacy of these therapies. ..